Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

1 May 2014 07:00

RNS Number : 9946F
Kingspan Group PLC
01 May 2014
 



 

KINGSPAN GROUP PLC

Interim Management Statement

1st May 2014

 

Kingspan Group plc, the global leader in high performance insulation, building fabric and solar integrated building envelopes, is issuing this Interim Management Statement in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

 

Overall Kingspan has experienced a strong start to the year with Continental Europe showing tentative signs of recovery, and the UK market being relatively buoyant across all key sectors we serve. Group sales of €561m in the first four months were 8% ahead of prior year, or 9% ahead at constant exchange rates.

 

The general pick-up in activity in the UK, which we saw in the final quarter of 2013, has continued into the early part of 2014. The Benelux market has shown early signs of recovery although industry activity is at relatively low levels, and Germany remains solid. In North America, our Insulated Panel business continues to advance driven by market penetration gains, however there is limited evidence of a wider market recovery in that region. The Middle East continues to be quite active, and Australia started the year well as penetration continues to grow.

 

Insulated Panel sales revenues were up 14% (+16% constant currency) in the first four months with all key markets recording growth, reflecting both penetration gains and increased market activity, compounded by a mild winter in Europe. The sales performance also reflects a good first quarter from Kingspan Energy which should be well positioned to deliver its full year sales target. In February, we completed the acquisition of Dri-Design®, a high-end architectural façades business in the US with annual revenues of c. $25m.

 

Insulation Board sales revenues were 3% ahead (+3% constant currency) in the first four months reflecting a busier UK market and an improving environment in the Benelux, albeit off a low base. The Group's next generation Insulation, Optim-R®, entered production in the UK during the period, and a new insulation board facility in Burkhardtsdorf in eastern Germany is scheduled to be fully commissioned by mid-year.

 

Access Floor sales revenues were 9% behind (-7% constant currency) in the first four months. UK sales were ahead, driven by a lively London office market, countered by a US office environment which is stubbornly slow to recover. There is some evidence of a potential improvement in office activity in the US for 2015.

 

Environmental sales revenues in the four month period were in line with the same period last year, as the divisional activity enters a more stable phase.

 

Net debt at the 25th April was €124m an increase of €16m from the position at last year end reflecting, in part, the US façades acquisition for €23.2m. The Group's funding position is robust and, as announced recently, was further helped by the recent re-pricing and term extension of the Group's syndicated bank facility to March 2019.

 

The Board wishes to thank David Byrne and Brian Hill who will retire today as Non-Executive Directors. We are very grateful to both David and Brian for their counsel and contribution to the Board during the past nine years.

 

Looking ahead, the order backlog across the Group points towards a strong first half for the business, albeit somewhat complimented by a favourable quarter one comparative, ahead of a more demanding second quarter comparison. Activity levels generally across our markets are encouraging. We remain mindful of the prevailing geo-political uncertainty and its potential to upset what has so far been a relatively nebulous recovery. Notwithstanding this, growing conversion, a strong innovation pipeline, and the greater worldwide focus on energy efficiency, leaves us confident about Kingspan's longer term future.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2014 on Tuesday 26 August 2014.

 

For further information contact:

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

Pat Walsh, Murray Consultants Tel: +353 (0) 1 4980300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRXXBGSG
Date   Source Headline
12th Feb 20145:32 pmRNSBlocklisting Application
5th Feb 201412:48 pmRNSHolding(s) in Company
2nd Jan 20143:19 pmRNSHolding(s) in Company
2nd Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 20147:00 amRNSTotal Voting Rights
16th Dec 201310:09 amRNSHolding(s) in Company
6th Dec 20135:43 pmRNSHolding(s) in Company
27th Nov 20135:21 pmRNSHolding(s) in Company
26th Nov 201310:51 amRNSHolding(s) in Company
22nd Nov 20137:00 amRNSInvestor & Analyst Seminar
19th Nov 201312:56 pmRNSHolding(s) in Company
14th Nov 20133:59 pmRNSHolding(s) in Company
13th Nov 20133:14 pmRNSDirector/PDMR Shareholding
11th Nov 20137:00 amRNSInterim Management Statement
7th Nov 201312:01 pmRNSHolding(s) in Company
1st Nov 201311:24 amRNSTotal Voting Rights
29th Oct 20134:53 pmRNSHolding(s) in Company
21st Oct 201310:52 amRNSDirector/PDMR Shareholding
15th Oct 20135:21 pmRNSHolding(s) in Company
1st Oct 20139:36 amRNSTotal Voting Rights
25th Sep 20131:00 pmRNSHolding(s) in Company
24th Sep 20131:06 pmRNSHolding(s) in Company
17th Sep 201310:02 amRNSDirector/PDMR Shareholding
2nd Sep 20139:47 amRNSTotal Voting Rights
19th Aug 20137:00 amRNSHalf Yearly Report
2nd Jul 20134:28 pmRNSHolding(s) in Company
1st Jul 201311:26 amRNSBlocklisting Interim Review
1st Jul 201311:23 amRNSTotal Voting Rights
14th Jun 201312:10 pmRNSHolding(s) in Company
12th Jun 20134:09 pmRNSHolding(s) in Company
4th Jun 20135:29 pmRNSDirector Declaration
4th Jun 201310:28 amRNSTotal Voting Rights
21st May 20134:44 pmRNSHolding(s) in Company
13th May 20135:40 pmRNSHolding(s) in Company
9th May 201310:56 amRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 201312:30 pmRNSTotal Voting Rights
11th Apr 20134:07 pmRNSHolding(s) in Company
5th Apr 20137:00 amRNSAnnual Financial Report
2nd Apr 201311:26 amRNSTotal Voting Rights
27th Mar 20134:34 pmRNSDirector/PDMR Shareholding
26th Mar 20134:20 pmRNSDirector/PDMR Shareholding
7th Mar 20136:25 pmRNSHolding(s) in Company
4th Mar 20133:19 pmRNSDirector/PDMR Shareholding
1st Mar 20137:00 amRNSTotal Voting Rights
26th Feb 201311:57 amRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSFinal Results
25th Feb 20137:00 amRNSMain Securities Market Notice
11th Feb 20135:03 pmRNSBlock Listing Application
6th Feb 20137:00 amRNSDirector Declaration - Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.